Doug Gould (@doug_gould1) 's Twitter Profile
Doug Gould

@doug_gould1

Researcher in critical care

ID: 2264752212

calendar_today27-12-2013 18:34:06

85 Tweet

152 Followers

517 Following

Intensive Care Medicine (@youricm) 's Twitter Profile Photo

#COVID19 critically ills in England, Wales & Northern Ireland ➑️ 10,834 pts overly non-white, from deprived areas more likely male/obese ➑️ 36.9% severe #ARDS P/F ≀100 ➑️ 72% invasive MV ➑️ high acute hospital mortality 42% vs other viral pneumonias 24.7% rdcu.be/b8sgN

#COVID19 critically ills in England, Wales & Northern Ireland
➑️ 10,834 pts overly non-white, from deprived areas more likely male/obese
➑️ 36.9% severe #ARDS P/F ≀100
➑️ 72% invasive MV
➑️ high acute hospital mortality 42% vs other viral pneumonias 24.7%
rdcu.be/b8sgN
ICNARC (@icnarc) 's Twitter Profile Photo

ICNARC proud to be the Clinical Trials Unit for remap-cap in the UK. Generating findings that can help save lives across ICUs globally. medrxiv.org/content/10.110…

ICNARC (@icnarc) 's Twitter Profile Photo

We estimate that the Phase 1 vaccination strategy potentially reduces numbers of patients becoming critically ill with COVID-19 substantially. For those not covered, older age remains dominant with males and some ethnic groups disproportionally represented osf.io/yks8c/

We estimate that the Phase 1 vaccination strategy potentially reduces numbers of patients becoming critically ill with COVID-19 substantially. For those not covered, older age remains dominant with males and some ethnic groups disproportionally represented osf.io/yks8c/
UK-ROX Trial (@ukroxtrial) 's Twitter Profile Photo

Fantastic news! We have now reached 100 patients recruited to the study in just over a month. We are so grateful for all the hard work being undertaken at every site and by the team ICNARC

ICNARC (@icnarc) 's Twitter Profile Photo

Important paper on delivery of data-enabled clinical trials. Our UK-ROX Trial funded through National Institute for Health and Care Research data-enabled trials call fully utilising the Case Mix Programme to hugely reduce data collection burden on sites and maximise efficiency.

UK-ROX Trial (@ukroxtrial) 's Twitter Profile Photo

We are excited to announce that the 500th patient has been randomised into the UK-ROX trial! Huge thank you to everyone involved for all their hard work. To celebrate this milestone, we have released our first newsletter - available for download here: icnarc.org/Our-Research/S…

ICNARC (@icnarc) 's Twitter Profile Photo

Please find our latest, now weekly report on patients critically ill with #Covid_19, reporting patients admitted from 1 May 2021 to date compared with patients admitted from 1 September 2020 to 30 April 2021. icnarc.org/Our-Audit/Audi…

TEAM (@teamtrialicu) 's Twitter Profile Photo

TEAM RCT only has 15 patients to go! We have had a strong start to recruitment in November, with 4 participants from 3 countries. Great #teamwork πŸŽ‰ Keep it up! Prof Carol Hodgson TEAM

TEAM (@teamtrialicu) 's Twitter Profile Photo

We are excited to announce that TEAM has officially completed recruitment! Thank you to all participating PIs, physios, RCs and study participants Participant #750 was recruited this morning from the wonderful TEAM at PAH Alicia Bowen Marc Nickels Prof Carol Hodgson anzicrc

Critical Care Reviews (@critcarereviews) 's Twitter Profile Photo

#CLASSICtrial manuscript is now published NEJM nejm.org/doi/full/10.10… editorial - nejm.org/doi/full/10.10… Many thanks NEJM for facilitating the publication with the results presentation at #CCR22 @TineMeyhoff @AndersPerner @MortenHylander

Critical Care Reviews (@critcarereviews) 's Twitter Profile Photo

Oxygen targets in PICU - the long awaited results of the OXY-PICU trial. Results from @pus27 & Doug Gould Thursday, June 15th, 0900 UTC+1 Join us in person or virtually criticalcarereviews.com/meetings/ccr23

Oxygen targets in PICU - the long awaited results of the OXY-PICU trial.
Results from @pus27  &amp; <a href="/Doug_Gould1/">Doug Gould</a> 
Thursday, June 15th, 0900 UTC+1

Join us in person or virtually
criticalcarereviews.com/meetings/ccr23
Dr Tracy Mitchell (@trakmitch) 's Twitter Profile Photo

Has your child been admitted to Paediatric Intensive Care (PICU) in the last three years or are you a patient and public involvement member of a paediatric clinical trial? Please help us design a clinical trial exploring multiple treatments in PICU. Contact me for more info.

Has your child been admitted to Paediatric Intensive Care (PICU) in the last three years or are you a patient and public involvement member of a paediatric clinical trial? Please help us design a clinical trial exploring multiple treatments in PICU. Contact me for more info.
National Institute for Health and Care Research (@nihrresearch) 's Twitter Profile Photo

A landmark NIHR-funded study has found that reducing oxygen levels for children in intensive care will save lives. The Oxy-PICU study was led by researchers from Great Ormond Street Hospital for Children and NIHR UCLH Biomedical Research Centre. Read more: nihr.ac.uk/news/reducing-…

A landmark NIHR-funded study has found that reducing oxygen levels for children in intensive care will save lives. The Oxy-PICU study was led by researchers from <a href="/GreatOrmondSt/">Great Ormond Street Hospital for Children</a> and <a href="/UCLHresearch/">NIHR UCLH Biomedical Research Centre</a>. Read more: nihr.ac.uk/news/reducing-…
Critical Care Reviews (@critcarereviews) 's Twitter Profile Photo

Delighted to announce that Prof Kathy Rowan Kathy Rowan will deliver the 2024 John Hinds Lecture at CCR24 "ICNARC at 30 - Back to the Future" Titanic Belfast June 12-14 criticalcarereviews.com/meetings/ccr24 Josephine Hinds

Delighted to announce that Prof Kathy Rowan <a href="/KathyRowan101/">Kathy Rowan</a> will deliver the 2024 John Hinds Lecture at CCR24

"ICNARC at 30 - Back to the Future"

Titanic Belfast
June 12-14
criticalcarereviews.com/meetings/ccr24

<a href="/DocJohnsMum/">Josephine Hinds</a>
JAMA (@jama_current) 's Twitter Profile Photo

Conservative oxygen therapy with a target SpO2 of 90% did not reduce 90-day all-cause mortality compared to usual oxygen therapy in mechanically ventilated adult patients. #CCR25 Critical Care Reviews ja.ma/43Ry4Ep

Conservative oxygen therapy with a target SpO2 of 90% did not reduce 90-day all-cause mortality compared to usual oxygen therapy in mechanically ventilated adult patients. 

#CCR25 <a href="/CritCareReviews/">Critical Care Reviews</a>

ja.ma/43Ry4Ep